期刊文献+

甲状腺髓样癌的预后影响因素——73例临床分析 被引量:7

Prognostic factors of medullary thyroid carcinoma: clinical analysis of 73 cases
暂未订购
导出
摘要 目的:探讨影响甲状腺髓样癌(MTC)预后的因素。方法:回顾性分析73例MTC手术治疗、术后放疗的临床和随访资料。结果:73例MTC中37例发生于30-40岁,女性多发,临床Ⅱ,Ⅲ期病例占到83.6%;根据有无颈部淋巴结肿大行癌灶局部广泛切除或甲状腺癌联合根治术,切除不满意者辅以术后放疗。治疗后Ⅰ期病例五年生存率达100%,Ⅲ期为41.5%,Ⅳ期为零。8例姑息性切除辅以放疗者无1例生存达到5年。结论:临床分期和癌灶及其转移淋巴结切除的彻底性是影响MTC预后的重要因素。肿物巨大而累及较广泛者,因有不完整的包膜而常能被完全切除,即使有少量癌灶残留,术后辅以放疗,也可取得较好的疗效,而不应轻易放弃手术治疗。 Purpose: To explore the prognostic factors of medullary thyroid carcinoma( MTC) . Methods: The current study was designed to collect and analyze the clinical and follow-up information of 73 cases of MTC treated in our hospital. Results: It was shown that 37 cases were patients aged 30-40 years, it was more common in female than male, 83. 6% of these cases were regarded as clinical stage Ⅰ toⅢ. After treatment, the survival rate for 5 years were 100% , 41. 5% and 0 in the group of clinical stage Ⅰ,Ⅲ and IV respectively. None of those 8 cases in which the masses were incompletely removed surgically combined with the postoperative radiotherapy survived up to 5 years. Conclusions: The clinical stage, the thoroughness of the remove of MTC and its metastasis were the significant prognostic factors in our patients. It should be recognized that in most cases of MTC, though the mass was huge, it could be removal completely because it has an incomplete capsule. Although a little cancerous tissue might be left after operation, the prognosis is good after the postoperative radiotherapy. Therefore attempts of surgical removal of the cancerous mass should not be given up easily.
作者 赵文川
出处 《中国癌症杂志》 CAS CSCD 2004年第2期167-169,共3页 China Oncology
关键词 甲状腺髓样癌 诊断 治疗 预后 medullary thyroid carcinoma diagnosis treatment prognosis
  • 相关文献

参考文献7

  • 1Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results of899 patients[J]. Clin Endocrinol,1998,48(3):265-273.
  • 2Corsello SM, Lovicu RM, Migneco MG, et al. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma[J]. Rays,2000,25(2): 257-266.
  • 3Schilling T, Burck J, Sinn HP, et al. Prognostic value of codon 918(ATG-ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma[J].Int J Cancer,2001,95(1):62-66.
  • 4Voutilainen PE, Multanen M, Haapiainen RK, et al. Long term prognosis of medullary thyroid carcinoma in 39 patients[J]. Ann Chir Gynaecol, 2000,89(4): 292 -297.
  • 5Raffaitin P,Hamy A, Mirallie E, et al. Prognostic factors of survival without clinical recurrences in medullary thyroid carcinoma: apropos of 52 operated cases. [J]. Ann Endocrinol,1999,60(6): 435-442.
  • 6Gbottger T, Klupp J, Sorger K, et al. Therapy and prognosis of medullary thyroid cancer[J]. Med Klin, 1991,86(1): 8-14.
  • 7李树玲.新编头颈肿瘤学[M].北京:人民卫生出版社,2000.638-640.

共引文献3

同被引文献42

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部